In combination with PD‐L1‐mediated checkpoint blockade therapy, the nanomedicine not only achieved a superior effect to suppress the growth of the primary tumor, but also promoted long‐lasting immune memory to inhibit tumor recurrence and metastasis (Figure 6l,m).[72]. Here, CD274 is linked to neoplasm.